Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Non Operating Income (2020 - 2025)

Treace Medical Concepts' Other Non Operating Income history spans 6 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 1215.7% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $1.3 million, changed N/A, while the annual FY2025 figure was -$2.7 million, N/A changed from the prior year.
  • Other Non Operating Income reached $2.7 million in Q4 2025 per TMCI's latest filing, up from -$612000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.0 million in Q4 2021 to a low of -$5.3 million in Q2 2022.
  • Average Other Non Operating Income over 5 years is -$377352.9, with a median of -$242000.0 recorded in 2024.
  • The largest YoY upside for Other Non Operating Income was 1215.7% in 2025 against a maximum downside of 340.91% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $3.0 million in 2021, then plummeted by 215.5% to -$3.5 million in 2022, then skyrocketed by 59.86% to -$1.4 million in 2023, then surged by 82.71% to -$242000.0 in 2024, then surged by 1215.7% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Other Non Operating Income are $2.7 million (Q4 2025), -$612000.0 (Q3 2025), and -$424000.0 (Q2 2025).